- Walker-Sperling, Victoria;
- Digitale, Jean C;
- Viard, Mathias;
- Martin, Maureen P;
- Bashirova, Arman;
- Yuki, Yuko;
- Ramsuran, Veron;
- Kulkarni, Smita;
- Naranbhai, Vivek;
- Li, Hongchuan;
- Anderson, Stephen K;
- Yum, Lauren;
- Clifford, Robert;
- Kibuuka, Hannah;
- Ake, Julie;
- Thomas, Rasmi;
- Rowland-Jones, Sarah;
- Rek, John;
- Arinaitwe, Emmanuel;
- Kamya, Moses;
- Rodriguez-Barraquer, Isabel;
- Feeney, Margaret E;
- Carrington, Mary
HLA class I (HLA-I) allotypes vary widely in their dependence on tapasin (TAPBP), an integral component of the peptide-loading complex, to present peptides on the cell surface. We identified two single-nucleotide polymorphisms that regulate TAPBP messenger RNA (mRNA) expression in Africans, rs111686073 (G/C) and rs59097151 (A/G), located in an AP-2α transcription factor binding site and a microRNA (miR)-4486 binding site, respectively. rs111686073G and rs59097151A induced significantly higher TAPBP mRNA expression relative to the alternative alleles due to higher affinity for AP-2α and abrogation of miR-4486 binding, respectively. These variants associated with lower Plasmodium falciparum parasite prevalence and lower incidence of clinical malaria specifically among individuals carrying tapasin-dependent HLA-I allotypes, presumably by augmenting peptide loading, whereas tapasin-independent allotypes associated with relative protection, regardless of imputed TAPBP mRNA expression levels. Thus, an attenuated course of malaria may occur through enhanced breadth and/or magnitude of antigen presentation, an important consideration when evaluating vaccine efficacy.